Default: Journal of Medicinal Chemistry

ISSN: 0022-2623

Journal Home

Journal Guideline

Journal of Medicinal Chemistry Q1 Unclaimed

American Chemical Society United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Medicinal Chemistry is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 301. It has a price of 3678 €. It has an SJR impact factor of 1,986 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,986.

Journal of Medicinal Chemistry focuses its scope in these topics and keywords: inhibitors, activity, synthesis, evaluation, derivatives, biological, receptor, potent, selective, agents, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


3678 €

Inmediate OA

1839 €

Embargoed OA

0 €

Non OA


Journal of Medicinal Chemistry


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

inhibitors, activity, synthesis, evaluation, derivatives, biological, receptor, potent, selective, agents, binding, structure, ligands, inhibitor, series, potential, acid, analogs, relationships, design, antitumor,

Best articles by citations

Influence of Various Central Moieties on the Hypolipidemic Properties of Long Hydrocarbon Chain Diols and Diacids

View more

Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors

View more

Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design

View more

Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension

View more

Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity

View more

The Oncolytic Efficacy and in Vivo Pharmacokinetics of [2-(4-Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) Are Governed by Distinct Stereochemical Features

View more

Biophysical Characterization of Zinc Ejection from HIV Nucleocapsid Protein by Anti-HIV 2,2'-Dithiobis[benzamides] and Benzisothiazolones

View more

No Denying It: Medicinal Chemistry Training Is in Big Trouble

View more

Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms

View more

AnN,N-Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A Novel Lanthionine Synthetase C-Like 2-Based Therapeutic for Inflammatory Bowel Disease

View more

Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1

View more

Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine beta-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors

View more

Synthesis, Structure-Activity Relationships, and Biological Studies of Chromenochalcones as Potential Antileishmanial Agents

View more

Pharmacophore Model To Discover OX1 and OX2 Orexin Receptor Ligands

View more

Substituted 2-Thioxoimidazolidin-4-ones and Imidazolidine-2,4-diones as Fatty Acid Amide Hydrolase Inhibitors Templates

View more

Structure-Activity Relationship and Signaling of New Chimeric CXCR4 Agonists

View more

Crystallographic Investigation of the Inhibition Mode of a VIM-2 Metallo-beta-lactamase fromPseudomonas aeruginosaby a Mercaptocarboxylate Inhibitor

View more

Structure-Activity Relationship of 6-Methylidene Penems Bearing Tricyclic Heterocycles as Broad-Spectrum beta-Lactamase Inhibitors: Crystallographic Structures Show Unexpected Binding of 1,4-Thiazepine Intermediates

View more

Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor

View more

Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors

View more

Structure-Activity Relationship Studies of Nordihydroguaiaretic Acid Inhibitors toward Soybean, 12-Human, and 15-Human Lipoxygenase

View more

Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli

View more

Synthesis of131I-Labeled Glucose-Conjugated Inhibitors ofO6-Methylguanine-DNA Methyltransferase (MGMT) and Comparison with Nonconjugated Inhibitors as Potential Tools for in Vivo MGMT Imaging

View more

Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains

View more